How CRISPR Actually Works: From Bacterial Immunity to Gene Therapy

In the late 1980s, researchers studying *E. coli* kept noticing a strange repeated pattern in the bacterial genome — short palindromic sequences separated by unique spacer DNA. It was catalogued but not understood for years. By 2007, Rodolphe Barrangou and colleagues at Danisco (yes, a yogurt company) figured out what it actually was: a bacterial immune memory system.

Bacteria face relentless viral attack. Bacteriophages inject their DNA, hijack the cell's machinery, and replicate. CRISPR — Clustered Regularly Interspaced Short Palindromic Repeats — is how bacteria remember past infections. When a bacterium survives an attack, it snips out a fragment of the phage DNA and tucks it between those palindromic repeats in its own genome. That archived sequence becomes the "wanted poster."

The clever part: when the same phage attacks again, the bacterium transcribes those spacers into short RNA molecules called crRNA (CRISPR RNA). These crRNAs patrol the cell, bound to protein complexes called Cas (CRISPR-associated). When crRNA matches an incoming phage DNA sequence, the Cas protein cuts it — destroying the invader before it can replicate.

Different bacterial species evolved different Cas proteins. *Streptococcus pyogenes* happens to produce Cas9, a single protein that does both the recognition and the cutting. That dual function is what made it so useful when Jennifer Doudna and Emmanuelle Charpentier figured out how to reprogram it in 2012 — work for which they received the Nobel Prize in Chemistry in 2020.

The fundamental insight: this isn't synthetic biology. It's biology we borrowed and repurposed. The machinery spent hundreds of millions of years being optimized by evolution. We just redirected it.

Not Invented Here: CRISPR Was Evolution's Spam Filter

// COMMENTS

ON THIS PAGE